Q1 2025 · CIK 1166559 Snapshot · — Export CSV
Manager file · GFT · GATES FOUNDATION TRUST

Bill & Melinda Gates Foundation Trust

EDGAR CIK 1166559 ↗ · Waiting · typical filing lag 45 days · EDGAR conformed name changed to Gates Foundation Trust; 13F-HR history continuous

Export CSV
Reported portfolio value
$41.81B
QoQ reported -0.5% · vs Q4 2024
Positions
25
1 new · 0 exited
Top 10 concentration
95.8%
largest position 25.6%
Position churn · Q1 2025
0 added · 1 trimmed
new positions 0.2% · exits 0.0% of book
Holdings · Q1 2025 · 25
Security Weight Δ wt Price* Shares Δ shares Value Action
1 MSFT MICROSOFT CORP 25.55% -3.0% $375 28.46M +0.0% $10.68B Held
2 BRK/B BERKSHIRE HATHAWAY INC DEL 21.88% +0.7% $533 17.17M -12.6% $9.15B Trimmed
3 WM WASTE MGMT INC DEL 17.85% +2.4% $232 32.23M +0.0% $7.46B Held
4 CNI CANADIAN NATL RY CO 12.78% -0.5% $97 54.83M +0.0% $5.34B Held
5 CAT CATERPILLAR INC 5.80% -0.5% $330 7.35M +0.0% $2.43B Held
6 DE DEERE & CO 3.99% +0.4% $469 3.56M +0.0% $1.67B Held
7 ECL ECOLAB INC 3.16% +0.3% $254 5.22M +0.0% $1.32B Held
8 WMT WALMART INC 1.91% -0.0% $88 9.09M +0.0% $798M Held
9 FDX FEDEX CORP 1.48% -0.2% $244 2.53M +0.0% $618M Held
10 KOF COCA-COLA FEMSA SAB DE CV 1.36% +0.2% $91 6.21M +0.0% $567M Held
11 WCN WASTE CONNECTIONS INC 1.00% +0.1% $195 2.15M +0.0% $419M Held
12 CPNG COUPANG INC 0.49% +0.0% $22 9.25M +0.0% $203M Held
13 CCI CROWN CASTLE INC 0.35% +0.0% $104 1.42M +0.0% $148M Held
14 SDGR SCHRODINGER INC 0.33% +0.0% $20 6.98M +0.0% $138M Held
15 MSGK MADISON SQUARE GRDN SPRT COR 0.28% -0.0% $195 592K +0.0% $115M Held
16 BUD ANHEUSER BUSCH INBEV SA/NV 0.25% +0.0% $62 1.70M +0.0% $105M Held
17 MCD MCDONALDS CORP 0.25% +0.0% $312 335K +0.0% $105M Held
18 WST WEST PHARMACEUTICAL SVSC INC 0.24% +0.2% $224 444K new $99.51M New
19 PCAR PACCAR INC 0.23% -0.0% $97 1.00M +0.0% $97.37M Held
20 UPS UNITED PARCEL SERVICE INC 0.20% -0.0% $110 755K +0.0% $83.05M Held
21 KHC KRAFT HEINZ CO 0.19% -0.0% $30 2.62M +0.0% $79.81M Held
22 DHR DANAHER CORPORATION 0.18% -0.0% $205 373K +0.0% $76.47M Held
23 HRL HORMEL FOODS CORP 0.16% -0.0% $31 2.20M +0.0% $67.92M Held
24 — ON HLDG AG 0.05% -0.0% $44 500K +0.0% $21.96M Held
25 VLTO VERALTO CORP 0.03% -0.0% $97 124K +0.0% $12.12M Held

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • WEST PHARMACEUTICAL SVSC INC 0.24% · $99.51M
  • none reported
  • Filing detail
    Period2025-03-31
    Accepted15 May 2025 · 16:16 ET
    Filing lag45 days
    Form13F-HR
    Information rows25
    Quarters on file14
    Portfolio value
    Q1 2023Q3 2023Q1 2024Q3 2024Q1 2025Q3 2025Q1 2026$47.78B Q1 2023Q3 2023Q1 2024Q3 2024Q1 2025Q3 2025Q1 202674
    Quarterly history · 14 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q2 2026 2026-06-30 $34.42B 24 21.4% 2 0 14 Aug 2026 ET 45
    Q1 2026 2026-03-31 $31.67B 22 25.8% 0 1 15 May 2026 ET 45
    Q4 2025 2025-12-31 $35.36B 23 27.6% 0 0 17 Feb 2026 ET 48
    Q3 2025 2025-09-30 $36.58B 23 29.9% 0 2 14 Nov 2025 ET 45
    Q2 2025 2025-06-30 $47.78B 25 27.3% 0 0 14 Aug 2025 ET 45
    Q1 2025 2025-03-31 $41.81B 25 25.6% 1 0 15 May 2025 ET 45
    Q4 2024 2024-12-31 $42.02B 24 28.5% 1 1 14 Feb 2025 ET 45
    Q3 2024 2024-09-30 $45.09B 24 27.6% 1 0 14 Nov 2024 ET 45
    Q2 2024 2024-06-30 $47.67B 23 32.7% 0 1 14 Aug 2024 ET 45
    Q1 2024 2024-03-31 $45.86B 24 33.5% 1 1 15 May 2024 ET 45
    Q4 2023 2023-12-31 $42.28B 24 34.0% 1 51 14 Feb 2024 ET 45
    Q3 2023 2023-09-30 $38.91B 74 31.9% 51 0 14 Nov 2023 ET 45
    Q2 2023 2023-06-30 $42.06B 23 31.8% 1 0 14 Aug 2023 ET 45
    Q1 2023 2023-03-31 $36.46B 22 31.0% — — 15 May 2023 ET 45
    Track record · return since filing
    Paper return of each reported book
    Since Q1 2023
    +66.3%
    S&P 500 +87.7%
    Hit rate · latest book
    74%
    priced positions with positive return
    Priced coverage
    100%
    of reported stock value
    Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q2 2026 +1.2% -4.1% +5.4% 100% BRK/B +17.7%
    Q1 2026 +9.8% +0.9% +8.9% 100% BRK/B +22.9%
    Q4 2025 +11.7% +9.6% +2.1% 100% BRK/B +17.9%
    Q3 2025 +19.1% +11.7% +7.4% 100% BRK/B +16.6%
    Q2 2025 +19.4% +16.7% +2.7% 100% BRK/B +23.8%
    Q1 2025 +21.1% +27.8% -6.7% 100% MSFT +16.1%
    Q4 2024 +27.7% +24.1% +3.6% 100% MSFT +29.4%
    Q3 2024 +26.9% +28.0% -1.1% 100% MSFT +24.0%
    Q2 2024 +32.5% +40.1% -7.6% 100% MSFT +27.2%
    Q1 2024 +29.9% +44.3% -14.3% 100% MSFT +25.4%
    Q4 2023 +35.2% +53.8% -18.6% 100% MSFT +29.7%
    Q3 2023 +54.2% +71.5% -17.4% 100% MSFT +44.0%
    Q2 2023 +57.7% +72.4% -14.6% 100% MSFT +64.9%
    Q1 2023 +66.3% +87.7% -21.4% 100% MSFT +73.1%
    Copy-trade simulation
    Hypothetical strategy
    +94.4%
    14 rebalances
    S&P 500 same window
    +87.7%
    excess +6.6%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.